Nisa Investment Advisors
BCAB icon

Nisa Investment Advisors’s BioAtla BCAB Stock Holding History

Nisa Investment Advisors’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1
Closed -$37 – 2969
2024
Q2 		$37 Hold
1
– – ﹤0.01% 2914
2024
Q1 		$124 Buy
+1
New +$124 ﹤0.01% 2697
2023
Q4 		– Sell
-1
Closed -$82 – 2648
2023
Q3 		$82 Buy
+1
New +$127 ﹤0.01% 2748
2022
Q2 		– Sell
-668
Closed -$167K – 2380
2022
Q1 		$167K Buy
+668
New +$279K ﹤0.01% 1452

Other funds holding BCAB

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Nisa Investment Advisors's BCAB Position: Q3 2024 in Review

Nisa Investment Advisors sold out of BioAtla (BCAB) in Q3 2024, closing a stake of 1 share — an estimated $37 sold.

Nisa Investment Advisors first reported a position in BCAB in Q1 2022 and held it in 4 quarters. The position peaked at $167K in Q1 2022. 63 funds tracked by Wall St. Rank hold BCAB as of Q3 2024.

  • Nisa Investment Advisors reported no remaining BioAtla position as of Q3 2024 after selling out during the quarter.
  • Nisa Investment Advisors sold 1 BioAtla share in Q3 2024, an estimated $37.
  • Nisa Investment Advisors first reported a position in BioAtla in Q1 2022 and held it in 4 quarters.
  • Nisa Investment Advisors's BioAtla position peaked at $167K in Q1 2022.
  • 63 funds tracked by Wall St. Rank held BioAtla as of Q3 2024.

Based on Nisa Investment Advisors's 13F filing for Q3 2024, filed 24 Oct 2024.